Equifax (NYSE:EFX) Now Covered by Oppenheimer

Key Points

• Oppenheimer has initiated coverage of Equifax with a rating of "outperform" and a target price of $271.00, suggesting about 17.77% upside potential from its recent closing price.
• Several brokerages have differing evaluations, with a consensus rating of "Moderate Buy" and a target price around $281.93, highlighting varying analyst confidence in the stock.
• Equifax reported a quarterly earnings of $2.00 EPS, surpassing expectations and demonstrating a 7.4% revenue increase year-over-year, setting future earnings guidance positively.

Investment analysts at Oppenheimer initiated coverage on shares of Equifax (NYSE:EFX - Get Free Report) in a research report issued to clients and investors on Monday,Briefing.com Automated Import reports. The firm set an "outperform" rating and a $271.00 price target on the credit services provider's stock. Oppenheimer's target price indicates a potential upside of 17.77% from the stock's previous close.

Several other brokerages have also weighed in on EFX. Royal Bank Of Canada reiterated an "outperform" rating and set a $300.00 price objective on shares of Equifax in a report on Wednesday, June 18th. Barclays reduced their price target on shares of Equifax from $260.00 to $240.00 and set an "equal weight" rating for the company in a research report on Wednesday, July 23rd. Weiss Ratings reissued a "hold (c+)" rating on shares of Equifax in a report on Wednesday, October 8th. Stifel Nicolaus increased their target price on shares of Equifax from $277.00 to $295.00 and gave the company a "buy" rating in a report on Wednesday, June 18th. Finally, Bank of America cut their price objective on Equifax from $285.00 to $250.00 and set a "neutral" rating on the stock in a research report on Friday, October 3rd. One equities research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $281.93.

Equifax Stock Down 1.3%

Shares of NYSE EFX opened at $230.11 on Monday. The firm has a market cap of $28.49 billion, a PE ratio of 45.03, a price-to-earnings-growth ratio of 2.70 and a beta of 1.68. The company has a debt-to-equity ratio of 0.79, a current ratio of 0.77 and a quick ratio of 0.77. Equifax has a 1 year low of $199.98 and a 1 year high of $294.92. The company has a 50 day simple moving average of $247.65 and a 200 day simple moving average of $251.24.

Equifax (NYSE:EFX - Get Free Report) last issued its quarterly earnings results on Tuesday, July 22nd. The credit services provider reported $2.00 EPS for the quarter, beating analysts' consensus estimates of $1.92 by $0.08. Equifax had a net margin of 10.95% and a return on equity of 18.89%. The business had revenue of $1.54 billion for the quarter, compared to analysts' expectations of $1.51 billion. During the same quarter in the prior year, the firm posted $1.82 earnings per share. The business's quarterly revenue was up 7.4% compared to the same quarter last year. Equifax has set its Q3 2025 guidance at 1.870-1.970 EPS. FY 2025 guidance at 7.330-7.630 EPS. On average, research analysts forecast that Equifax will post 7.58 EPS for the current year.

Insider Activity at Equifax

In related news, CEO Mark W. Begor sold 48,264 shares of Equifax stock in a transaction on Monday, July 28th. The shares were sold at an average price of $241.71, for a total value of $11,665,891.44. Following the transaction, the chief executive officer owned 142,872 shares in the company, valued at $34,533,591.12. This trade represents a 25.25% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 1.40% of the company's stock.

Hedge Funds Weigh In On Equifax

Hedge funds and other institutional investors have recently modified their holdings of the company. Vanguard Group Inc. increased its holdings in Equifax by 1.8% during the 2nd quarter. Vanguard Group Inc. now owns 14,966,903 shares of the credit services provider's stock valued at $3,881,966,000 after purchasing an additional 258,572 shares during the period. Price T Rowe Associates Inc. MD boosted its holdings in Equifax by 40.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 7,037,804 shares of the credit services provider's stock valued at $1,714,129,000 after acquiring an additional 2,009,987 shares in the last quarter. State Street Corp increased its position in Equifax by 1.4% during the 2nd quarter. State Street Corp now owns 4,968,897 shares of the credit services provider's stock valued at $1,288,783,000 after purchasing an additional 66,914 shares during the period. Harris Associates L P raised its holdings in Equifax by 27.6% in the 1st quarter. Harris Associates L P now owns 4,570,557 shares of the credit services provider's stock worth $1,113,205,000 after purchasing an additional 987,772 shares in the last quarter. Finally, Geode Capital Management LLC lifted its position in shares of Equifax by 2.5% in the 2nd quarter. Geode Capital Management LLC now owns 3,142,763 shares of the credit services provider's stock worth $811,650,000 after purchasing an additional 75,627 shares during the period. 96.20% of the stock is owned by institutional investors.

About Equifax

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.